Stay updated on IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib

Sign up to get notified when there's something new on the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page.
Latest website image capture
Clouds background image

Latest updates to the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows a 403 Forbidden message, replacing the previous study record content with a basic header. This change eliminates access to the detailed study information and related sections that were previously visible on the page.
    Difference
    19%
    Check dated 2026-09-25T20:42:13.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, indicating an update to the site’s template or documentation; this is a minor version increment that does not modify the study content.
    Difference
    0.0%
    Check dated 2026-09-18T17:27:55.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Added an NIH grant/contract identifier for 2017 to the study's identifiers. Updated the page revision to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-28T19:21:13.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    A new publication citation regarding hyperprogressive disease in the IMbrave150 trial was added to the study publications, and the page revision was updated from v3.6.4 to v3.6.5.
    Difference
    0.0%
    Check dated 2026-08-07T12:35:14.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the previous v3.6.3. This indicates an internal update to the page version used for rendering and tracking changes.
    Difference
    0.0%
    Check dated 2026-07-24T01:41:27.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page’s Revision label was updated from v3.6.1 to v3.6.3, signaling a newer release of the page’s documentation. This appears to be a minor metadata update without changes to the study content or navigation.
    Difference
    0.0%
    Check dated 2026-07-02T13:00:01.000Z thumbnail image

Stay in the know with updates to IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib

Enter your email address, and we'll notify you when there's something new on the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page.